Kabra Drugs

  • Market Cap: Micro Cap
  • Industry: Pharmaceuticals & Biotechnology
  • ISIN: INE323K01017
  • NSEID:
  • BSEID: 524322
INR
18.61
-0.97 (-4.95%)
BSENSE

Nov 20

BSE+NSE Vol: 55.32 k

  • Price Points
  • Score
  • Mojo Parameters
  • Total Return
  • News and Corporate Actions
  • Key factors
  • Shareholding
  • Financials
  • CompanyCV
stock-recommendationAnnual Results
Results Snapshot
Figures in Cr
Standalone - Balance Sheet Results
Mar'26
Mar'25
Mar'24
Mar'23
Mar'22
Mar'21
Balance Sheet Analysis Highlights
stock-summary

Borrowings

YoY Growth in year ended Mar 2026 is -2.27% vs -74.27% in Mar 2025

stock-summary

Other Long Term Liabilities

No Other Long Term Liabilities in the last few periods;

stock-summary

Fixed Assets

YoY Growth in year ended Mar 2026 is 1,675.00% vs 0.00% in Mar 2025

stock-summary

Investments

No Investments in the last few periods;

stock-summary

Current Assets

YoY Growth in year ended Mar 2026 is 240.37% vs 442.20% in Mar 2025

Compare Balance Sheet Results of Kabra Drugs
Markets Mojo
Figures in Cr
Standalone - Balance Sheet Results
Markets Mojo
Markets Mojo
Change(INR)
Change(%)
No of Months
12
12
EQUITY AND LIABILITIES
Share Capital
23.71
15.83
7.88
49.78%
Share Warrants & Outstandings
Total Reserve
5.91
87.49
-81.58
-93.24%
Shareholder's Funds
29.61
103.32
-73.71
-71.34%
Minority Interest
0.00
0.00
0.00
0.00%
Long-Term Borrowings
0.00
7.50
-7.50
-100.00%
Secured Loans
0.00
3.63
-3.63
-100.00%
Unsecured Loans
0.00
3.87
-3.87
-100.00%
Deferred Tax Assets / Liabilities
0.01
5.20
-5.19
-99.81%
Other Long Term Liabilities
0.11
2.63
-2.52
-95.82%
Long Term Trade Payables
0.00
0.00
0.00
0.00%
Long Term Provisions
0.00
0.00
0.00
0.00%
Total Non-Current Liabilities
0.12
15.33
-15.21
-99.22%
Current Liabilities
Trade Payables
54.88
68.86
-13.98
-20.30%
Other Current Liabilities
1.28
24.71
-23.43
-94.82%
Short Term Borrowings
0.43
94.56
-94.13
-99.55%
Short Term Provisions
0.00
1.36
-1.36
-100.00%
Total Current Liabilities
56.58
189.49
-132.91
-70.14%
Total Liabilities
86.32
308.14
-221.82
-71.99%
ASSETS
Non-Current Assets
0.00
0.00
0.00
0.00%
Gross Block
0.75
275.73
-274.98
-99.73%
Less: Accumulated Depreciation
0.04
137.78
-137.74
-99.97%
Less : Impairment of Assets
0.00
0.00
0.00
0.00%
Net Block
0.71
137.95
-137.24
-99.49%
Lease Adjustment
0.00
0.00
0.00
0.00%
Capital Work in Progress
0.00
0.00
0.00
0.00%
Intangible assets under development
0.00
3.88
-3.88
-100.00%
Pre-operative Expenses pending
0.00
0.00
0.00
0.00%
Assets in transit
0.00
0.00
0.00
0.00%
Non Current Investments
0.00
0.03
-0.03
-100.00%
Long Term Loans & Advances
1.51
0.28
1.23
439.29%
Other Non Current Assets
0.00
0.00
0.00
0.00%
Total Non-Current Assets
2.35
152.45
-150.10
-98.46%
Current Assets Loans & Advances
Current Investments
0.00
0.00
0.00
0.00%
Inventories
0.00
102.77
-102.77
-100.00%
Sundry Debtors
70.78
40.30
30.48
75.63%
Cash and Bank
10.58
0.67
9.91
1,479.10%
Other Current Assets
0.00
0.81
-0.81
-100.00%
Short Term Loans and Advances
2.61
11.13
-8.52
-76.55%
Total Current Assets
83.97
155.69
-71.72
-46.07%
Net Current Assets (Including Current Investments)
27.38
-33.80
61.18
181.01%
Total Current Assets Excluding Current Investments
83.97
155.69
-71.72
-46.07%
Miscellaneous Expenses not written off
0.00
0.00
0.00
0.00%
Total Assets
86.32
308.14
-221.82
-71.99%
Contingent Liabilities
0.48
10.00
-9.52
-95.20%
Total Debt
0.43
102.06
-101.63
-99.58%
Book Value per share (adjusted)
12.49
0.00
12.49
0.00%
Annual - Borrowings
Borrowings 0.43 Cr
in Mar 2026

Figures in Cr
stock-summary

YoY Growth in year ended Mar 2026 is -2.27% vs -74.27% in Mar 2025

Annual - Other Long Term Liabilities
Other Long Term Liabilities 0.11 Cr
in Mar 2026

Figures in Cr
stock-summary

No Other Long Term Liabilities in the last few periods;

Annual - Fixed Assets
Fixed Assets 0.71 Cr
in Mar 2026

Figures in Cr
stock-summary

YoY Growth in year ended Mar 2026 is 1,675.00% vs 0.00% in Mar 2025

Annual - Investments
Markets Mojo
No Investments in the last few periods
stock-summary

No Investments in the last few periods;

Annual - Current Assets
Current Assets 83.97 Cr
in Mar 2026

Figures in Cr
stock-summary

YoY Growth in year ended Mar 2026 is 240.37% vs 442.20% in Mar 2025